Abbott Laboratories (VIE:ABT)

Market Cap	184.30B
Revenue (ttm)	37.37B
Net Income (ttm)	11.87B
Shares Out	n/a
EPS (ttm)	6.78
PE Ratio	15.53
Forward PE	22.33
Dividend	2.11 (1.99%)
Ex-Dividend Date	Oct 15, 2025

Volume	n/a
Average Volume	3
Open	106.30
Previous Close	107.26
Day's Range	105.78 - 106.44
52-Week Range	104.36 - 134.20
Beta	n/a
RSI	42.18
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD